Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LIAISON NES Flu A/B & COVID-19 Clinical Agreement in Australia

NCT05897515 is registered in ClinicalTrials.gov with DiaSorin Molecular LLC as lead sponsor.

NCT NCT05897515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05897515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LIAISON NES Flu A/B & COVID-19 Clinical Agreement in Australia
Lead sponsor
DiaSorin Molecular LLC
Phase
Not applicable
Overall status
Completed
Start date
June 19, 2023
Completion date
October 31, 2023
Enrollment
233 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus disease 2019, influenza a, influenza type b